Enumeral Biomedical Holdings, Inc. — Form D

Enumeral Biomedical Holdings, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-08-13. The offering totals $21.5M, of which $21.5M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Barry B BucklandDirectorCambridge, MA
Allan B RothsteinDirectorCambridge, MA
Arthur H TinkelenbergDirectorCambridge, MA
Daniel B WolfeDirectorMontclair, NJ
Derek J BrandExecutive OfficerCambridge, MA
Anhco J NguyenExecutive OfficerCambridge, MA
Kevin J SarneyExecutive OfficerCambridge, MA
Arthur H TinkelenbergExecutive OfficerCambridge, MA
Wael FayadDirectorNew York, NY
Wael FayadExecutive OfficerNew York, NY
Paul J SekhriDirectorHigh Point, NC
Robert L Van NostrandDirectorNew York, NY
Barry G Buckland, Ph.D.DirectorCambridge, MA
Robert J EastonDirectorCambridge, MA
Allan P RothsteinDirectorCambridge, MA
Kevin G SarneyExecutive OfficerCambridge, MA
Arthur H Tinkelenberg, Ph.D.DirectorCambridge, MA
Anhco H Nguyen, Ph.D.Executive OfficerCambridge, MA
John J RydzewskiDirectorCambridge, MA
John J RydzewskiExecutive OfficerCambridge, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2017-05-25D$3.6M$668K
2016-12-15D$10.8M$3.4M
2016-08-02D$3.5M$3.0M
2014-08-13D$25.1M$25.1M

More